NIFTY
6.10  0.06%
 11053.90
S&P BSE SENSEX
52.16  0.14%
 37402.49
Sun Pharmaceutical Industries Ltd.
NSE : SUNPHARMA BSE : 524715 ISIN code : INE044A01036
on 19-Aug-2019
NSE
11.3    2.72%
Rs. 426.00
 
Days Low
Rs. 421.1
Days High
Rs. 434.2

Open Rs. 425.4
 
52 week Low
Rs. 350.4
52 week High
Rs.678.8
 
 
Bid :                 425.80 (954)
Offer :        0.00 (0)
BSE
Rs.425.80
11.05    2.66%
on 19-Aug-2019
BSE
11.05    2.66%
Rs. 425.80
 
Days Low
Rs. 421
Days High
Rs. 434.2

Open Rs. 424.75
 
52 week Low
Rs. 344.55
52 week High
Rs.679.3
 
 
Bid :                 425.80 (954)
Offer :        0.00 (0)
NSE
Rs.426.00
11.3    2.72%
 
 
Last Price (Rs.)  425.80 Value  291275057.00
Net Change (Rs.)  11.05 Best Buy  425.80
Volume  681556 Best Sell  0.00
Prev.Close (Rs.)  414.75 Best Quantity  954
Open (Rs.)  425.40 Sell Quantity  0
High (Rs.)  434.20 52-Week High (Rs.)  678.80
Low (Rs.)  421.10 52-Week Low (Rs.)  350.40
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  1021636.83
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital2399.30 2399.30 2399.30 
Share Capital2399.30 2399.30 2399.30 
Share Capital2399.30 2399.30 2399.30 
Share Capital2399.30 2399.30 2399.30 
Share Capital2399.30 2399.30 2399.30 
Currents Investments2479.50 447.60 400.10 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Dr. Reddys Lab 2510.50 417029 791.79 32.63 0.80
Divis Lab 1517.75 402915 272.75 30.23 1.05
Cipla 475.90 383522 203.91 20.30 0.63
Ranbaxy Labs. 859.90 366028 1.53 0.00 0.00
Piramal Enterprises 1797.40 357407 1174.23 0.00 1.56
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Jun 2019Mar 2019Dec 2018
Net Sales33090.1025521.3022612.60
Operating Profit9609.7012377.302023.70
PBDT9037.2011183.60689.90
Net Profit7633.7010680.60-386.80
More> 
 
Company News
8/17/2019 12:00:00 AM
Sun Pharma, CMS ink licensing agreement for generic products in Mainla...
8/14/2019 12:00:00 AM
CONCOR, Infosys and Wipro to see some action today
8/14/2019 12:00:00 AM
Sun Pharma enters into licensing agreement with CSIR-IICT
More>
 
Ratios
   Earnings Per Share (Rs)3.40 
   Book NAV/Share(Rs)95.21 
   PAT Margin (%)6.58 
   Asset Turnover(x)0.33 
   PER(x)140.81 
   Yield(%)0.57 
   EV/Core EBITDA(x)39.99 
   M Cap / Sales11.16 
   Net Sales Growth(%)14.70 
   PAT Growth(%)167.18 
   Total Debt/Equity(x)0.28 
   Current Ratio(x)0.84 
   Quick Ratio(x)0.63 
   Total Debt/Mcap(x)0.06 
More>